Introduction of New Therapeutic Substances

In table XW0, Introduction of Anatomical Regions, six new substance values were added for the substances listed below. These substances have the qualifier value New Technology Group 12. Device/Substance/Technology 4 Elamipretide 5 Ifezuntirgene Inilparvovec 6 Landiolol Antiarrhythmic 7 Zimislecel Allogeneic Stem Cell-derived Islet Cell Therapy Elamipretide Elamipretide is administered subcutaneously to improve muscle strength in adults and patients with Barth syndrome. Barth syndrome is characterized by mucocutaneous blistering, nail deformities, and the absence of skin on the legs and feet. Elamipretide targets mitochondrial dysfunction to regulate cellular damage, inflammation, and disease progression. Ifezuntirgene Inilparvovec Ifezuntirgene Inilparvovec is an experimental...

Subscribe or sign in to view the full article.

articles:    index next
  • The official AHA publication for ICD-10-CM and ICD-10-PCS coding guidelines and advice
  • Current newsletters added each quarter
  • Full Archives - over 3100 articles
  • ALL years/issues back to 1984 organized by year and issue
  • Includes ICD-10-CM/PCS Articles since 2013
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - ICD-10-CM/PCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.

Aimee - AI-powered coding assistant Would you like Aimee - AI
to help you with this?